Immunic (IMUX) Other Non-Current Assets (2013 - 2023)
Immunic (IMUX) posted Other Non-Current Assets of $43000.0 for Q3 2023, little changed sequentially from $43000.0 in Q2 2023, and up 2.38% YoY from $42000.0 in Q3 2022.
Immunic (IMUX) Other Non-Current Assets (2013 - 2023) Analysis & Trends
Immunic has reported Other Non-Current Assets for 11 years, with the latest figure at $43000.0 in Q3 2023.
- Quarterly Other Non-Current Assets rose 2.38% year-over-year to $43000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $43000.0 (up 2.38% YoY) and the FY2022 annual result came in at $43000.0, up 2.38% from the prior year.
- Other Non-Current Assets held at $43000.0 in Q3 2023 per IMUX's latest filing, from $43000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $43000.0 in Q4 2022 and troughed at $12000.0 in Q1 2019.
- A 5-year average of $40470.6 and a median of $42000.0 in 2019 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2019 and 2020: Other Non-Current Assets tumbled 88.12% in 2019, then soared 250.0% in 2020.
- Over 5 years, Other Non-Current Assets stood at $42000.0 in 2019, then changed by 0.0% to $42000.0 in 2020, then changed by 0.0% to $42000.0 in 2021, then advanced by 2.38% to $43000.0 in 2022, then changed by 0.0% to $43000.0 in 2023.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $43000.0, $43000.0, and $43000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Immunic | 682.77 Mn | 682.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 43,000.00 |
| Dec 31, 2022 | 43,000.00 |
| Sep 30, 2022 | 42,000.00 |
| Jun 30, 2022 | 42,000.00 |
| Mar 31, 2022 | 42,000.00 |
| Dec 31, 2021 | 42,000.00 |
| Sep 30, 2021 | 42,000.00 |
| Jun 30, 2021 | 42,000.00 |
| Mar 31, 2021 | 42,000.00 |
| Dec 31, 2020 | 42,000.00 |
| Sep 30, 2020 | 42,000.00 |
| Jun 30, 2020 | 42,000.00 |
| Mar 31, 2020 | 42,000.00 |
| Dec 31, 2019 | 42,000.00 |
| Mar 31, 2019 | 12,000.00 |
| Sep 30, 2018 | 37,000.00 |
| Jun 30, 2018 | 97,000.00 |
| Mar 31, 2018 | 101,000.00 |